CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer

Changhoon Yoo, Sung-Bae Kim, Jungsil Ro, Seock-Ah Im, Young-Hyuck Im, Jee Hyun Kim, Jin-Hee Ahn, Kyung Hae Jung, Hong Suk Song, Seok Yun Kang, Hee Sook Park, Hyun-Cheol Chung

Cancer Research and Treatment. 2016;48(2):499-507. Published online 2015 July 14 DOI: https://doi.org/10.4143/crt.2015.089

Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer

Changhoon Yoo, Sung-Bae Kim, Jungsil Ro, Seock-Ah Im, Young-Hyuck Im, Jee Hyun Kim, Jin-Hee Ahn, Kyung Hae Jung, Hong Suk Song, Seok Yun Kang, Hee Sook Park, Hyun-Cheol Chung

Cancer Research and Treatment. 2016;48(2):499-507

Link1

Link2 Link3

56PD Quality of life in TSU-68 study: Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline

B.S. Sohn, S.B. Kim, J.-H. Ahn, K.H. Jung, K.S. Lee, J. Ro, S.-A. Im, Y.-H. Im, H.-S. Song, H.-S. Park, H.C. Chung

Annals of Oncology. 2015;26:ix16

Link1 Link2

5058 POSTER Randomized Phase II Multicenter Trial of Oral Antiangiogenic Agent TSU-68 in Combination With Docetaxel Versus Docetaxel Alone in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline

S. Kim, J.H. Ahn, J. Ro, S.A. Im, Y.H. Im, J.H. Kim, H.S. Song, S.Y. Kang, H.S. Park, H.C. Chung

European Journal of Cancer. 2011;47:S347

Link1 Link2

Quality of life on TSU-68: Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline

Byeong Seok Sohn, Sung-Bae Kim, Jin-Hee Ahn, Kyung Hae Jung, Jeongeun Kim, Keun Seok Lee, Jungsil Ro, Seock-Ah Im, Young-Hyuck Im, Hong Suk Song, Hee Sook Park, Hyun-Cheol Chung

Asia-Pacific Journal of Clinical Oncology. 2017;13(6):365-371

Link1 Link2

Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: Randomized phase II multicenter trial

Sung-Bae Kim, Changhoon Yoo, Jungsil Ro, Seock-Ah Im, Young-Hyuck Im, Jee Hyun Kim, Jin-Hee Ahn, Kyung Hae Jung, Hong Suk Song, Seok Yun Kang, Hee Sook Park, Hyun-Cheol Chung

Investigational New Drugs. 2014;32(4):753-761

Link1

Link2 Link3 Link4

Quantification of Cell-Free HER-2 DNA in Plasma from Breast Cancer Patients: Sensitivity for Detection of Metastatic Recurrence and Gene Amplification

Patricia Diana Sørensen, Rikke Fredslund Andersen, Niels Pallisgaard, Jonna Skov Madsen, Erik Hugger Jakobsen, Ivan Brandslund

Journal of Circulating Biomarkers. 2015;4:9

Link1 Link2 Link3

A multicenter phase II study of TSU-68, an oral multiple tyrosine kinase inhibitor, in combination with docetaxel in metastatic breast cancer patients with anthracycline resistance

Masakazu Toi, Toshiaki Saeki, Hiroji Iwata, Kenichi Inoue, Yutaka Tokuda, Yasuyuki Sato, Yoshinori Ito, Kenjiro Aogi, Yuichi Takatsuka, Hitoshi Arioka

Breast Cancer. 2012;21(1):20-27

Link1

Link2 Link3

Antiangiogenic Therapy in Patients With HER2-Positive Metastatic Breast Cancer: A Case Series

Olivia Le Saux, Benoît You, Gilles Freyer

Clinical Breast Cancer. 2014;14(3):e89-e94

Link1 Link2

A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinoma

Fumihiko Kanai, Haruhiko Yoshida, Ryosuke Tateishi, Shinpei Sato, Takao Kawabe, Shuntaro Obi, Yuji Kondo, Makoto Taniguchi, Kazumi Tagawa, Masafumi Ikeda, Chigusa Morizane, Takuji Okusaka, Hitoshi Arioka, Shuichiro Shiina, Masao Omata

Cancer Chemotherapy and Pharmacology. 2010;67(2):315-324

Link1

Link2 Link3

Incorporation of Antiangiogenic Therapies in the Treatment of Metastatic Breast Cancer

Foluso O. Ademuyiwa, Kathy D. Miller

Clinical Breast Cancer. 2008;8:S151-S156

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.